Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04334876 · ClinicalTrials.gov registry record · NA
Rapid SARS-CoV-2 IgG Antibody Testing in High Risk Healthcare Workers
A NA study, sponsored by Indiana University.
- Completed
- Registry status
- NA
- Development phase
- 571
- Enrollment target
NCT04334876 is a NA study that has completed, run by Indiana University. The registered enrollment target is 571 participants.
The verdict
NCT04334876, a NA study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- NA
- Development phase
- 571 participants
- Enrollment target
Study Summary
The purpose of this study is to validate the use of a rapid, at home, point-of-care (POC) SARS-CoV-2 IgG antibody test in high risk healthcare workers. Additionally, we would like to evaluate the incidence of seroconversion in this high-risk population and to identify possible candidates for convalescent plasma donation for therapy/prophylaxis.
Interventions
- DIAGNOSTIC_TEST SARS-CoV-2 IgG Antibody Testing Kit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 571 participants |
| Start Date | 2020-04-01 |
| Est. Completion | 2021-01-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04334876
The ClinicalTrials.gov registry entry for NCT04334876 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 571 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which SARS-CoV-2 IgG Antibody Testing Kit is the first listed.
NCT04334876 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04334876 about?
NCT04334876 is a clinical study titled "Rapid SARS-CoV-2 IgG Antibody Testing in High Risk Healthcare Workers". The purpose of this study is to validate the use of a rapid, at home, point-of-care (POC) SARS-CoV-2 IgG antibody test in high risk healthcare workers. Additionally, we would like to evaluate the incidence of seroconversion in this high-risk population and to identify possible candidates for convale...
What is the current status of trial NCT04334876?
This trial is currently completed. It is a NA study. The enrollment target is 571 participants. The study started on 2020-04-01. Estimated completion is 2021-01-01.
What interventions are being tested in trial NCT04334876?
The interventions under investigation include: SARS-CoV-2 IgG Antibody Testing Kit (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04334876?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.